| View |
|
DRP-12326
|
Betamethasone (as Dipropionate)
|
Bellis
|
500mcg/g (0.05% w/w)
|
Cream
|
Corticosteroid
|
S Kant Healthcare Limited
|
India
|
Initial
|
20 July 2022
|
20 July 2027
|
| View |
|
DRP-12347
|
Carnitine Orotate + Liver Extract Antitoxic Fraction +
Adenine Hydrochloride + Pyridoxine Hydrochloride +
Riboflavin + Cyanocobalamin
|
Godex DS
|
300 mg + 25 mg + 5 mg + 50 mg + 1 mg + 250 mcg
|
Capsule
|
Hepatoprotector
|
Marnets Pharma Corporation
|
Philippines
|
Initial
|
27 July 2022
|
27 July 2027
|
| View |
|
DRP-12349
|
Finasteride
|
Saphteride-5
|
5 mg
|
Film coated Tablet
|
Testosterone-5-alpha reductase inhibitor
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
22 July 2022
|
22 July 2027
|
| View |
|
DRP-12344
|
Ketotifen (as fumarate
|
Netofen
|
1 mg/ 5 mL
|
Syrup
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Initial
|
21 July 2022
|
21 July 2027
|
| View |
|
DR-XY48213
|
Iohexol
|
Exovell
|
755 mg/ mL (eq. to 350 mg/ mL of Iodine)
|
Solution for Injection (Intravenous/ Intra-arterial/
Intrathecal/ Body Cavities)
|
Non-Ionic Radiocontrast Media
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Initial
|
22 July 2022
|
22 July 2027
|
| View |
|
DR-XY48212
|
Iohexol
|
Exovell
|
647 mg/mL (eq. to 300 mg/ mL of Iodine)
|
Solution for Injection (Intravenous/ Intra-arterial/
Intrathecal/ Body Cavities)
|
Non-Ionic Radiocontrast Media
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Initial
|
22 July 2022
|
22 July 2027
|
| View |
|
DR-XY48211
|
Imipenem +Cilastatin Sodium
|
Imiclast
|
500 mg/ 500 mg
|
Powder for Solution for Infusion (I.V.)
|
Antibacterial (Carbapenem)
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Initial
|
22 July 2022
|
22 July 2027
|
| View |
|
DR-XY48221
|
Ceftazidime
|
Eozidime-1000
|
1 g
|
Powder for Solution for Injection (I.M./1.V.)
|
Antibacterial (Cephalosporin)
|
Zee Laboratories Limited
|
India
|
Initial
|
25 July 2022
|
25 July 2027
|
| View |
|
DR-XY39070
|
NEBIVOLOL
|
NEVIBLOC
|
5 mg
|
Tablet
|
BETA-BLOCKING AGENT
|
Ajanta Pharma Limited
|
India
|
Renewal
|
22 July 2022
|
21 February 2029
|
| View |
|
DRP-3175-01
|
ATORVASTATIN (AS CALCIUM)
|
ORVAST
|
40mg
|
Film-Coated Tablet
|
ANTIHYPERLIPIDEMIC
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2024
|
04 January 2030
|
| View |
|
DRP-3175-02
|
ATORVASTATIN (AS CALCIUM)
|
MEVAGARD
|
40mg
|
Film-Coated Tablet
|
ANTIHYPERLIPIDEMIC
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
13 October 2024
|
04 January 2030
|
| View |
|
DRP-3493-09
|
Multivitamins + Buclizine Hydrochloride
|
Buclirich
|
Each 5 mL Syrup contains: Retinol Acetate (Vitamin A) Cholecalciferol (Vitamin D3) Alpha Tocopheryl Acetate Ascorbic Acid (Vitamin C) Niacinamide Buclizine Hydrochloride
2,000 IU 200 IU 1 IU 60 mg
D-Panthenol Thiamine Hydrochloride (Vitamin B1) Riboflavin-5-Phosphate Sodium (Vitamin B2) Pyridoxine Hydrochloride (Vitamin B6) Cyanocobalamin (Vitamin B12)
3 mg 1 mg 1 mg 1 mg 1 mcg
18 mg
5 mg
|
Syrup
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial [CLIDP] (Compliance) correction
|
13 October 2022
|
28 February 2026
|
| View |
|
DRP-11345-01
|
Vancomycin Hydrochloride
|
Vancosar 500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
12 August 2022
|
03 March 2027
|
| View |
|
BRP-114
|
Lactobacillus gasseri + Lactobacillus rhamnosus
|
Ecovag
|
Hard Vaginal Capsule
|
|
-
|
Deerland Probiotics & Enzymes A/S
|
Denmark
|
PCPR Conversion
|
16 August 2022
|
20 September 2026
|
| View |
|
HRP-417-04
|
TRETINOIN + HYDROQUINONE
|
WHITENING PEEL # 14
|
10mg/2g per 100mL (0.01%/2%)
|
TOPICAL SOLUTION
|
EXFOLIANT / ANTI-ACNE / DEPIGMENTING
|
REFINETTE COSMETIC MANUFACTURING CORPORATION
|
Philippines
|
CLIDP Conversion
|
16 August 2022
|
15 March 2026
|
| View |
|
DRP-1063-14
|
Prednisone
|
Betpred
|
10 mg/5 mL
|
Suspension
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
16 August 2022
|
11 May 2026
|
| View |
|
DRP-4474-15
|
Ceftriaxone (as sodium)
|
3-Gen 1000
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporins)
|
Brawn Laboratories Ltd.
|
India
|
Renewal
|
17 October 2022
|
13 June 2028
|
| View |
|
DRP-5407-08
|
Co-Amoxiclav
|
Amoxirife
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
28 March 2024
|
30 July 2029
|
| View |
|
DRP-6569-02
|
Isotretinoin
|
Actame
|
10 mg
|
Softgel Capsule
|
Anti-acne
|
Phil Inter Pharma Co., Ltd. (Plant 1)
|
Vietnam
|
Renewal
|
17 February 2023
|
15 November 2028
|
| View |
|
DRP-6570-09
|
CEFUROXIME (AS SODIUM)
|
ZOCEF HOSPI
|
750 MG
|
POWDER FOR INJECTION (I.M./I.V.)
|
ANTIBACTERIAL
|
NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD
|
China
|
Automatic Renewal
|
23 January 2024
|
10 March 2029
|